2015 - Sheila Essey Award for ALS Research, American Academy of Neurology
Adriano Chiò mainly focuses on Amyotrophic lateral sclerosis, Genetics, Incidence, Epidemiology and Internal medicine. His Amyotrophic lateral sclerosis research incorporates elements of Physical therapy and Neuroscience. His studies deal with areas such as Global health, Demography, Surgery and Pediatrics as well as Incidence.
His work in Epidemiology covers topics such as Prospective cohort study which are related to areas like Respiratory function and Severity of illness. The various areas that Adriano Chiò examines in his Internal medicine study include Gastroenterology and Endocrinology. Adriano Chiò combines subjects such as C9orf72 Protein, Trinucleotide repeat expansion and UBQLN2 with his study of TARDBP.
His main research concerns Amyotrophic lateral sclerosis, Internal medicine, Disease, Pathology and Genetics. His Amyotrophic lateral sclerosis study integrates concerns from other disciplines, such as Epidemiology, Frontotemporal dementia, Physical therapy, Neuroscience and Cohort. His research investigates the connection with Epidemiology and areas like Incidence which intersect with concerns in Demography.
His research in Internal medicine intersects with topics in Gastroenterology and Oncology. His work carried out in the field of Disease brings together such families of science as Neurology and Intensive care medicine. His work on Genetics deals in particular with Gene, TARDBP, C9orf72, Missense mutation and Mutation.
His primary scientific interests are in Amyotrophic lateral sclerosis, Disease, Internal medicine, Frontotemporal dementia and Clinical trial. His research integrates issues of Genetics, Cognition, Neuroscience, C9orf72 and Cohort in his study of Amyotrophic lateral sclerosis. His study on Disease also encompasses disciplines like
His Internal medicine research incorporates themes from Gastroenterology, Oncology and Cardiology. His Frontotemporal dementia research is multidisciplinary, incorporating elements of Genetic heterogeneity, Hypermetabolism, Neurodegeneration and Neuropsychological assessment. His Clinical trial research includes elements of Respiratory function, Placebo, MEDLINE and Intensive care medicine.
Adriano Chiò spends much of his time researching Amyotrophic lateral sclerosis, Disease, Internal medicine, Clinical trial and Cohort. His Amyotrophic lateral sclerosis research integrates issues from Genetics, Logistic regression, Dementia, Frontotemporal dementia and Cognition. Adriano Chiò has included themes like Referral, Neuroimaging and Median survival in his Frontotemporal dementia study.
As a member of one scientific family, he mostly works in the field of Disease, focusing on Family history and, on occasion, Trinucleotide repeat expansion, Comorbidity, Weakness, Wasting and Bioinformatics. In his study, Precentral gyrus, Hypermetabolism, Precuneus, Fluorodeoxyglucose and Superior frontal gyrus is strongly linked to Cardiology, which falls under the umbrella field of Internal medicine. Adriano Chiò has researched Clinical trial in several fields, including MEDLINE, Randomized controlled trial, Intensive care medicine, Placebo and Riluzole.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD
Alan E. Renton;Elisa Majounie;Adrian James Waite;Javier Simón-Sánchez;Javier Simón-Sánchez.
State of play in amyotrophic lateral sclerosis genetics
Alan E Renton;Adriano Chiò;Bryan J Traynor.
Nature Neuroscience (2014)
Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Janel O. Johnson;Jessica Mandrioli;Michael Benatar;Yevgeniya Abramzon.
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
Elisa Majounie;Alan E. Renton;Kin Mok;Elise G. P. Dopper;Elise G. P. Dopper.
Lancet Neurology (2012)
EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) : revised report of an EFNS task force
Peter M. Andersen;Sharon Abrahams;Gian D. Borasio;Mamede de Carvalho.
European Journal of Neurology (2012)
Incidence of amyotrophic lateral sclerosis in Europe
Giancarlo Logroscino;Bryan J Traynor;Orla Hardiman;Adriano Chiò.
Journal of Neurology, Neurosurgery, and Psychiatry (2010)
Prognostic factors in ALS: A critical review
Adriano Chiò;Giancarlo Logroscino;Orla Hardiman;Robert Swingler.
Amyotrophic Lateral Sclerosis (2008)
Global Epidemiology of Amyotrophic Lateral Sclerosis: a Systematic Review of the Published Literature
A. Chiò;G. Logroscino;B.J. Traynor;J. Collins.
Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players
Adriano Chiò;Gianmartino Benzi;Maurizia Dossena;Roberto Mutani.
Controversies and priorities in amyotrophic lateral sclerosis
Martin R Turner;Orla Hardiman;Michael Benatar;Benjamin R Brooks.
Lancet Neurology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: